Renegade Prepares for Belmont Stakes After Close Kentucky Derby Finish
Quantinuum Sets IPO Terms Targeting Nearly 13 Billion Valuation in Quantum Computing Debut
US Economy Rebounds in First Quarter of 2026 Eye On Housing Reports
US 10Year Treasury Yields Could Outperform Eurozone Peers on Policy Divergence
Ashok Leyland Q4 Profit Rises 14 to Rs 1291 Crore Announces Rs 25 Interim Dividend
TotalEnergies Extends French Fuel Price Caps Through June
Mirion Technologies MIR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises
DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress
FR Q1 2026 Earnings Massive EPS Beat Drives Positive Market Reaction
TENX Q1 2026 Earnings NarrowerThanExpected Loss Signals Continued Cost Discipline
Wintrust Financial WTFCN Q1 2026 Earnings Solid EPS Beat Driven by Strong Net Interest Income
DPRO Q1 2026 Earnings Narrowly Misses EPS Estimates No Revenue Reported
Brookfield Infrastructure Corporation 7250 Subordinated Notes due 2084 BIPJ Modest Dip Amid Steady Income Appeal
Enterprise Products Partners EPD Slips 3 as Energy Sector Faces Headwinds
Scholar Rock SRRK Surges Nearly 7 as Biotech Momentum Builds
Sunstone Hotel Investors SHO Rises Over 2 Breaking Above Key Resistance Levels
Jyong Biotech Ltd MENS Gains 337 as Technical Support Holds Resistance in Focus
Leonardo DRS Inc DRS Q1 2026 Earnings EPS Surges Past Estimates as Defense Demand Remains Robust
TXMD Q3 2023 Earnings EPS Misses Estimates by Wide Margin Amidst Operational Challenges
ATER Q3 2025 Earnings EPS Surpasses Estimates by Over 56 Stock Rises
GOVX Q1 2026 Earnings Narrower Loss Surprises Shares Surge Over 32
LGN Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction
April Jobs Report Preview Labor Market Cooling but Stable Economists Anticipate
Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress
Doximity Inc DOCS Holds Near Support After Modest Decline
Blue Owl Capital OBDC Slightly Down Holds Between Defined Support and Resistance Levels
LB Pharmaceuticals LBRX Holds Near Resistance as Modest Gain Signals Consolidation
Biogen BIIB Posts 2 Gain as Stock Tests Resistance Near 207
LEIFRAS LFS Slips 287 as Stock Tests Key Support at 286
Genelux Corporation GNLX Gains 3 Amid Renewed Interest Key Levels to Watch
Smith Nephew SNN Sheds 113 as Stock Tests Key Support Levels
Columbia Sportswear COLM Rallies 38 as Shares Bounce From Key Support Level